ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Carbonic Anhydrase II

Carbonic Anhydrase II

概要

Name:Carbonic anhydrase II
Target Synonym:Carbonic anhydrase II,Carbonic Anhydrase B,EC:4.2.1.1,Carbonate Dehydratase II,Carbonic Anhydrase C,EC 4.2.1.1,CA2,Epididymis Luminal Protein 76,Car2,HEL-76,Epididymis Secretory Protein Li 282,CA-II,CAC,CAII,HEL-S-282,Carbonic Anhydrase 2,Carbonic Dehydratase
Number of Launched Drugs:5
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
CA2-H5228 Human Human Carbonic Anhydrase II / CA2 Protein, His Tag
CA2-H5228-structure
CA2-H5228-sds
ACRO Quality

Synonym Name

CA2,CA-II,CAII,Car2

Background

Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes. CAs form a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons (or vice versa), a reversible reaction that occurs rather slowly in the absence of a catalyst. One of the functions of the enzyme in animals is to interconvert carbon dioxide and bicarbonate to maintain acid-base balance in blood and other tissues, and to help transport carbon dioxide out of tissues. The active site of most carbonic anhydrases contains a zinc ion. They are, therefore, classified as metalloenzymes. There are at least five distinct CA families (¦Á, ¦Â, ¦Ã, ¦Ä and ¦Å). These families have no significant amino acid sequence similarity and in most cases are thought to be an example of convergent evolution. The ¦Á-CAs are found in humans. Carbonic anhydrase II (CA2) is also known as Carbonate dehydratase II, Carbonic anhydrase C, is one of fourteen forms of human ¦Á carbonic anhydrases. Defects in this enzyme are associated with osteopetrosis and renal tubular acidosis. Renal carbonic anhydrase allows the reabsorption of sodium ions in the proximal tubule. Carbonic anhydrase II has been shown to interact with Band 3 and Sodium-hydrogen antiporter 1.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sultiame Riker-594 Approved Ospolot Sleep Apnea, Obstructive; Epilepsy Details
Topiramate KW-6485P; McN-4853; RWJ-17021; W-6485; TPM; SPN-538; USL-255 Approved Janssen Global Services Llc Topamax, Topina, Conviban, Qudexy, Eprontia, 妥泰 United States Lennox Gastaut Syndrome Upsher-Smith Laboratories Llc 1995-01-01 Gambling; Cognition; Obsessive-Compulsive Disorder; Sciatica; Epilepsy, Absence; Tobacco Use Disorder; Tourette Syndrome; Migraine with Aura; Alcoholism; Epilepsy, Generalized; Epilepsy; Hypoxia-Ischemia, Brain; Parkinson Disease; Epilepsy, Tonic-Clonic; Stress Disorders, Post-Traumatic; Cocaine-Related Disorders; Alcohol Drinking; Migraine without Aura; Obesity; Lymphoma; Hyperlipidemias; Heart Defects, Congenital; Mental Disorders; Vascular Headaches; Affective Disorders, Psychotic; Binge Drinking; Alcohol-Induced Disorders; Migraine Disorders; HIV Infections; Pediatric Obesity; Hypertriglyceridemia; Peripheral Nervous System Diseases; Weight Loss; Binge-Eating Disorder; Seizures; Contraception; Epilepsies, Partial; Diabetes Mellitus, Type 2; Headache; Marijuana Abuse; Mood Disorders; Bipolar Disorder; Essential Tremor; Diabetic Neuropathies; Polyneuropathies; Bulimia; Obesity, Morbid; Pain, Postoperative; Lennox Gastaut Syndrome; Hypertension Details
Para-Toluenesulfonamide p-TSA; PTS-02; PTS-100; PTS-302; PTS; PTS-500 Approved Gongwin Biopharm Co Ltd, Beijing Jiandakang New Drug Development Co Ltd Mainland China Carcinoma, Non-Small-Cell Lung Tianjin Hongri Jiandakang Medical Technology Co Ltd 2022-11-15 Liver Neoplasms; Solid tumours; Carcinoma, Adenoid Cystic; Airway Obstruction; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details
Brinzolamide AL-4862; ALO-4862 Approved Alcon 派立明, Azopt Japan Ocular Hypertension; Glaucoma, Open-Angle Alcon 1998-04-01 Glaucoma, Open-Angle; Ocular Hypertension; Glaucoma Details
Brinzolamide/Timolol Maleate Approved Alcon Azarga Mainland China Ocular Hypertension; Glaucoma, Open-Angle Alcon Laboratories (U.K.) Ltd 2008-11-25 Glaucoma, Open-Angle; Ocular Hypertension; Glaucoma Details
Brinzolamide/Brimonidine Tartrate Approved Novartis Pharma Ag Simbrinza Mainland China Ocular Hypertension; Glaucoma, Open-Angle Novartis Europharm Ltd 2013-04-19 Glaucoma, Open-Angle; Ocular Hypertension Details

This web search service is supported by Google Inc.

totopphone